Drug Price Hike Threatens Life Expectancy in Nigeria, Experts Warn

In a growing crisis, the cost of essential drugs in Nigeria has skyrocketed, raising fears of increased mortality and a significant reduction in life expectancy. Experts warn that this drastic surge in the prices of common medications such as malaria treatments, antibiotics, and drugs for diabetes and hypertension is placing a severe strain on Nigerians’ health and finances.

Retail prices for commonly used drugs have soared by at least 300 percent in a matter of months, with no signs of abatement. The crisis is exacerbated by soaring inflation, with food inflation reaching 40.01 percent in March and the pharmaceutical inflation rate experiencing exponential growth over the past four months.

A recent market survey in Abuja revealed staggering price hikes. Antibiotics and malaria drugs like Tavernic jumped to ₦25,735 from ₦11,370 in January, while Levofloxacin SGS rose to ₦1,200 from ₦550. Terivid tablet 200mg escalated from ₦4,460 to ₦10,320, and Coartem 80/480 shot up from ₦1,750 to ₦6,500. Other essential medications followed a similar trend, with Ventolin inhaler now priced at ₦9,000, up from ₦2,000, and Augmentin 625mg rising from ₦14,200 to ₦25,000.

These price increases have left many Nigerians struggling to afford medication, creating life-threatening situations. Community pharmacist Blessing Adams shared the tragic story of a patient who died because they couldn’t afford an inhaler, and a hypertensive patient who passed away due to the inability to afford antihypertensive drugs.

The crisis is not just impacting individual patients; it also threatens the broader healthcare system. Dr. Uche Ojinmah, President of the Nigerian Medical Association, highlighted that the rising cost of medications has already led to a surge in the death rate and a decline in life expectancy. He urged the government to declare an emergency in the health sector to prevent further collapse.

The high prices of medications are driving many Nigerians towards alternative treatments, including herbal remedies, as conventional drugs become unaffordable. This shift raises concerns about the quality and safety of alternative treatments.

Additionally, the current foreign exchange crisis, coupled with Nigeria’s heavy reliance on imported medications and rising energy costs, has exacerbated the problem. The Naira recently closed at ₦1,234.49 per dollar, adding to the financial strain. The electricity tariff hike of 240 percent also contributes to rising production and distribution costs.

The Nigerian government, led by President Bola Ahmed Tinubu, has discussed plans for an executive order to curb the surge in drug prices, but concrete measures have yet to be implemented. Experts suggest that tax waivers for imported medicines and pharmaceuticals, as well as support for local drug production, could be critical steps to address the crisis.

Despite the grim outlook, experts believe that with immediate action and a focus on local drug manufacturing, the Nigerian government can mitigate the impact of the drug price hike and ensure that affordable, high-quality medication is accessible to all citizens. Without such measures, the country’s health system may face an unprecedented crisis, leading to a further decline in life expectancy and rising mortality rates.